Brookfield Asset Management Inc. Invitae Corp Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 16, 2022	BUY	$2.13 - $9.01 $49,305 - $208,563	23,148 New	23,148 $56,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $7,120 - $30,120	-3,343 Reduced 12.62%	23,148 $56,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $62,787 - $155,868	9,998 Added 60.62%	26,491 $211,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $10,319 - $20,126	702 Added 4.45%	16,493 $251,000
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $345,708 - $595,317	10,457 Added 196.04%	15,791 $603,000

Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $423,618 - $622,043	-10,837 Reduced 67.02%	5,334 $223,000
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $459,741 - $722,358	16,171 New	16,171 $701,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.